Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer. (Record no. 29714900)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02236 a2200625 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250518041446.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 202008s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1557-3265 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1158/1078-0432.CCR-18-4275 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Hu-Lieskovan, Siwen |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20200819 |
| 245 00 - TITLE STATEMENT | |
| Title | Tumor Characteristics Associated with Benefit from Pembrolizumab in Advanced Non-Small Cell Lung Cancer. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Date of publication, distribution, etc. | 08 2019 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 5061-5068 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antibodies, Monoclonal, Humanized |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Agents, Immunological |
| General subdivision | administration & dosage |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Carcinoma, Non-Small-Cell Lung |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Immunohistochemistry |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Lung Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Molecular Targeted Therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Grading |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Metastasis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neoplasm Staging |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Exome Sequencing |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Lisberg, Aaron |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Zaretsky, Jesse M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Grogan, Tristan R |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Rizvi, Hira |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Wells, Daniel K |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Carroll, James |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Cummings, Amy |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Madrigal, John |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jones, Benjamin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Gukasyan, Jacklin |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Shintaku, I Peter |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Slamon, Dennis |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Dubinett, Steven |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Goldman, Jonathan W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Elashoff, David |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hellmann, Matthew D |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Ribas, Antoni |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Garon, Edward B |
| 773 0# - HOST ITEM ENTRY | |
| Title | Clinical cancer research : an official journal of the American Association for Cancer Research |
| Related parts | vol. 25 |
| -- | no. 16 |
| -- | p. 5061-5068 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1158/1078-0432.CCR-18-4275">https://doi.org/10.1158/1078-0432.CCR-18-4275</a> |
| Public note | Available from publisher's website |
No items available.